Lifecome Biochemistry Co.,Ltd. (SHE:002868)
23.72
+0.21 (0.89%)
Jul 18, 2025, 3:04 PM CST
Lifecome Biochemistry Revenue
Lifecome Biochemistry had revenue of 141.92M CNY in the quarter ending March 31, 2025, a decrease of -11.52%. This brings the company's revenue in the last twelve months to 630.90M, up 11.23% year-over-year. In the year 2024, Lifecome Biochemistry had annual revenue of 649.37M with 28.08% growth.
Revenue (ttm)
630.90M
Revenue Growth
+11.23%
P/S Ratio
5.84
Revenue / Employee
702.56K
Employees
898
Market Cap
3.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
Dec 31, 2020 | 308.15M | 4.39M | 1.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |